Conservation and Propagation of Scarcity Valuable Plant Species Having Useful Biological Activity

具有有用生物活性的稀缺珍贵植物物种的保护和繁殖

基本信息

  • 批准号:
    10557237
  • 负责人:
  • 金额:
    $ 4.16万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

We have already succeeded in propagation of the clone of Ephedra plant in many Himalayas medicinal plants. Since Ephedra plant is an important medicinal plant which is very often used as an oriental medicine, called "kanpo medicine", its propagation and cultivation were strongly expected. Now, many clone plants obtained by the plant tissue culture method are cultivated and actively grow in our medicinal plant garden. The cultivated Ephedra plant contained the same components as those of the original plant of the crude drug which is used as kanpo medicine. The excellent clone plant is expected to be used as substitute for the Chinese Ephedra plant, which in future the import from China is concerned to be stopped by the Government.In 1999 to 2000, we carried out the similar experiment to it of Ephedra using the Panax and Bupleurum plants, which both are used as the original plant of kanpo medicine. Many Panax and Bupleurum plants were collected from various areaa of Nepal, and studied of the morphological, genetical and chemical characteristics. As the result, it was evidently shown that Himalayan Panax plant contained very similar saponin components to Korean ginseng. Now the Panax plants are cultured in vitro using plant biotechnology. On the other hand, 16 species of Bupleurum plants collected from various areas of Nepal showed to be rich in variety of the saponin component and/or content. It was investigated that its differences were derived from the genetical character or the habitat. As the results, it was suggested that the variety of the saponin component corresponded with the genetical variation and the saponin content with the habitat.
我们已经成功地在喜马拉雅山的许多药用植物中繁殖了麻黄属植物的克隆。麻黄是一种重要的药用植物,常被用作东方药材,被称为“坎坡药”,其繁殖和栽培一直备受关注。现在,许多通过植物组织培养方法获得的克隆植物在我们的药用植物园中被栽培和活跃地生长。栽培麻黄中含有与坎坡药原植物相同的成分。1999年至2000年,我们以坎坡药的原植物人参和柴胡为材料,进行了与麻黄相似的实验,并对麻黄的优良无性系植物进行了筛选。从尼泊尔不同地区采集了大量的人参和柴胡属植物,对其形态、遗传和化学特性进行了研究。结果表明,喜马拉雅人参中含有与高丽参非常相似的皂苷成分。目前,人参属植物的离体培养是利用植物生物技术进行的。另一方面,从尼泊尔不同地区采集的16种柴胡属植物显示出丰富的皂苷组分和/或含量。研究表明,其差异主要来自于遗传性状或生境。结果表明,皂甙组分的变化与遗传变异相一致,皂甙含量与生境有关。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawaguchi Kiichiro: "[Immunopharmacological Activities of Plant Flavonoids] ed. By [Society for the Conservation and Development of Himalayan Medicinal Resources (SCDHMR) JAPAN]"Proceedings of Nepal-Japan Joint Symposium-2000. (in press). (2002)
川口喜一郎:“[植物类黄酮的免疫药理学活性]编辑,作者:[日本喜马拉雅药用资源保护与开发协会 (SCDHMR)]”尼泊尔-日本联合研讨会记录 - 2000 年。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe Takashi: "[Field Survey of the Medicinal Plant Resources in the Himalayas and Their Conservation] ed. By [Society for the Conservation and Development of Himalayan Medicinal Resources (SCDHMR) JAPAN]"Proceedings of Nepal-Japan Joint Symposium-200
渡边隆:“[喜马拉雅山药用植物资源实地调查及其保护]编辑[喜马拉雅药用资源保护与开发协会(SCDHMR)日本]”尼泊尔-日本联合研讨会论文集-200
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe Takashi: "Studies on the medicinal plant resources of the Himalayas (3) ;Random amplified polymorphic DNA analysis and saponin contents of Himalayan ginseng [Panax pseudo-ginseng Wall.]"Natural Medicines. 52. 426-433 (1998)
渡边隆:《喜马拉雅山药用植物资源研究(3);喜马拉雅山人参[Panaxpseudo-ginsengWall]的随机扩增多态性DNA分析及皂苷含量》《天然药物》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
川口基一郎,吉川孝文 他: "Colony stimulating factor-inducing activity of hesperidin"Planta Medica. 65. 365-366 (1999)
Kiichiro Kawaguchi、Takafumi Yoshikawa 等:“橙皮苷的集落刺激因子诱导活性”Planta Medica 65. 365-366 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshikawa Takafumi: "Proceedings of Nepal-Japan Joint Symposium-2000"Society for the Conservation and Development of Himalayan Medicinal Resources (SCDHMR), JAPAN (印刷中). (2002)
Yoshikawa Takafumi:“2000 年尼泊尔-日本联合研讨会论文集”喜马拉雅药用资源保护与开发协会 (SCDHMR),日本(2002 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIKAWA Takafumi其他文献

YOSHIKAWA Takafumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIKAWA Takafumi', 18)}}的其他基金

Bone and skin regeneration therapy with bone marrow mesenchymal cells
骨髓间充质细胞的骨和皮肤再生治疗
  • 批准号:
    15500319
  • 财政年份:
    2003
  • 资助金额:
    $ 4.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research of tissue engineering using gene engineering technique
利用基因工程技术进行组织工程研究
  • 批准号:
    12680841
  • 财政年份:
    2000
  • 资助金额:
    $ 4.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
an in vivo or in vitro expression of c-SRC gene in bone formation on materials.
c-SRC基因在材料上骨形成中的体内或体外表达。
  • 批准号:
    08680931
  • 财政年份:
    1996
  • 资助金额:
    $ 4.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidation of molecular mechamism of growth factor receptors downregulation by Ephedra Herb and application to molecular target drug-resistance non-small cell lung cancer
麻黄下调生长因子受体的分子机制阐明及其在分子靶向耐药非小细胞肺癌中的应用
  • 批准号:
    20K07790
  • 财政年份:
    2020
  • 资助金额:
    $ 4.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of pharmacological actions of Ephedra Herb through stimulation of endocytosis
麻黄通过刺激内吞作用的药理作用分析
  • 批准号:
    17K09321
  • 财政年份:
    2017
  • 资助金额:
    $ 4.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Action mechanism of Ephedra Herb drug group against influenza virus infection
麻黄药组抗流感病毒感染的作用机制
  • 批准号:
    23590896
  • 财政年份:
    2011
  • 资助金额:
    $ 4.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了